In this episode of Thread by Thread, we dive into the electrifying and complex world of biotechnology—where cutting-edge science meets global power struggles. Through the story of a Danish geneticist suddenly cut off from a decade-long collaboration, we explore how biotech has become a new frontline in geopolitics.

Discover how a booming $546 billion industry is transforming medicine, innovation, and national security all at once. We'll unpack the soaring investments, shifting supply chains, and rising export controls that are reshaping the biotech landscape. Then, zoom out to the geopolitical tensions driving a “biotech cold war” — with the U.S. and China racing to control genetic data, supply chains, and revolutionary therapies.

What does all this mean for patients waiting for life-saving treatments, startups navigating fractured markets, and the future of global scientific collaboration? Join us as we pull the threads connecting economics, politics, and human stories in the biological century.